Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09C ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN
C09CA Angiotensin II receptor blockers (ARBs), plain
C09CA09 Azilsartan medoxomil
D08865 Azilsartan kamedoxomil (USAN) <US>
USP drug classification [BR:br08302]
Cardiovascular Agents
Angiotensin II Receptor Antagonists
Azilsartan
D08865 Azilsartan kamedoxomil (USAN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01925 Renin-angiotensin system inhibitor
DG01495 Angiotensin II receptor antagonist
DG00351 Azilsartan
D08865 Azilsartan kamedoxomil
DG03231 Antihypertensive
DG01495 Angiotensin II receptor antagonist
DG00351 Azilsartan
D08865 Azilsartan kamedoxomil
Drug classes [BR:br08332]
Cardiovascular agent
DG01495 Angiotensin II receptor antagonist
D08865 Azilsartan kamedoxomil
DG03231 Antihypertensive
D08865 Azilsartan kamedoxomil
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Angiotensin
AGTR1
D08865 Azilsartan kamedoxomil (USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D08865
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D08865
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D08865
Drug groups [BR:br08330]
Cardiovascular agent
DG01925 Renin-angiotensin system inhibitor
DG01495 Angiotensin II receptor antagonist
DG00351 Azilsartan
DG03231 Antihypertensive
DG01495 Angiotensin II receptor antagonist
DG00351 Azilsartan